Results 131 to 140 of about 14,825 (199)

Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors. [PDF]

J Clin Med Res
Patel J, Shah S, Reddy A, Prajapati D, Pandya A, Sawhney S.   +5 more
europepmc   +1 more source

Design of the Japan Kidney Association-Pemafibrate Intervention for Chronic Kidney Disease patients Study (JKAPI-CKD Study). [PDF]

Clin Kidney J
Kinguchi S, Tamura K, Yano Y, Nangaku M, Isaka Y, Maruyama S, Kanegae H, Heerspink HL, Nakagawa N, Nishio S, Asahi K, Yamagata K, Fukui A, Okada H, Narita I, Tsuruya K, Wada J, Terada Y, Mukoyama M, Imai E, Yokota N, Kobayashi K, Kashihara N.   +22 more
europepmc   +1 more source

TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis. [PDF]

NeuroSci
Flourou C, Dietis N, Tsiordas S, Hadjigeorgiou G, Vavougios GD.   +4 more
europepmc   +1 more source

Cholestatic and autoimmune liver diseases, bile duct injury, oxidative stress, and therapeutic strategies. [PDF]

Front Physiol
Stygar D, Bogielski B, Michalczyk K, Skrzep-Poloczek B, Suchocka A, Nikiel K, Kukla K, Wasek R, Staniszewski J, Matyja M, Kukla M.   +10 more
europepmc   +1 more source

Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases. [PDF]

Front Pharmacol
Watanabe S, Nagura K, Okada N, Watanabe T, Sagara H.   +4 more
europepmc   +1 more source

Correction to "Acute pancreatitis caused by severe hypertriglyceridemia in a 61-year-old man on a carnivore diet". [PDF]

CMAJ
europepmc   +1 more source

Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective. [PDF]

Am J Gastroenterol
Bowlus CL, Bittencourt PL, Bobat B, Gulamhusein A, Kowdley K, Levy C, Lleo A, Ma X, Tanaka A.   +8 more
europepmc   +1 more source

Is FH a curable disease? [PDF]

Glob Cardiol Sci Pract
Seidah NG.
europepmc   +1 more source

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Chronic Liver Diseases: Translating Mechanistic Insights into Clinical Practice and Future Perspectives. [PDF]

Cells
Romeo M, Basile C, Imperatore A, Mozzi G, Di Nardo F, Napolitano C, Vaia P, Di Puorto L, Indipendente M, Dallio M, Federico A.   +10 more
europepmc   +1 more source

Triglyceride-lowering therapies for hepatic steatosis: mechanisms, efficacy, and clinical perspectives. [PDF]

Front Pharmacol
Tamehri Zadeh SS, Toth PP, Banach M.
europepmc   +1 more source